Creative Planning’s Tourmaline Bio TRML Stock Holding History

Creative Planning’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13,287	Closed	-$636K	–	4107
2025 Q3	$636K	Buy	13,287 +695	+6%	+$19.3K	﹤0.01%	2522
2025 Q2	$201K	Buy	+12,592	New	+$204K	﹤0.01%	3214
2025 Q1	–	Sell	-109	Closed	-$2.21K	–	3720
2024 Q4	$2.21K	Buy	+109	New	+$2.75K	﹤0.01%	3457

Creative Planning's TRML Position: Q4 2025 in Review

Creative Planning sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 13,287 shares — an estimated $636K sold.

Creative Planning first reported a position in TRML in Q4 2024 and held it in 3 quarters. The position peaked at $636K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Creative Planning reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Creative Planning sold 13,287 Tourmaline Bio shares in Q4 2025, an estimated $636K.
Creative Planning first reported a position in Tourmaline Bio in Q4 2024 and held it in 3 quarters.
Creative Planning's Tourmaline Bio position peaked at $636K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Creative Planning's 13F filing for Q4 2025, filed 17 Feb 2026.